IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Executive Function in Learning in Children With Attention Deficit Hyperactivity Disorder (ADHD) Receiving Medical Treatment Alone Compared to Children Receiving Additional Treatment to Improve Learning Strategies
The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2012 by Hillel Yaffe Medical Center.
Recruitment status was: Not yet recruiting
Recruitment status was: Not yet recruiting
Sponsor:
Hillel Yaffe Medical Center
Information provided by (Responsible Party):
Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT01531127
First received: February 8, 2012
Last updated: February 9, 2012
Last verified: February 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine whether there is a difference in executive function in learning in children with ADHD receiving medical treatment alone to the executive function in children receiving, in addition to medical treatment in learning strategies.
| Condition |
|---|
| ADHD |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
Further study details as provided by Hillel Yaffe Medical Center:
Primary Outcome Measures:
- Level of Executive Functioning [ Time Frame: One year ]Brief Behavior Rating Inventory of Executive Function will be administered
| Estimated Enrollment: | 30 |
| Study Start Date: | March 2012 |
| Estimated Study Completion Date: | March 2013 |
| Estimated Primary Completion Date: | March 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Combined Therapy
ADHD Medication and Learning Strategies Treatment
|
|
ADHD Medication Treatment
Control group
|
Eligibility| Ages Eligible for Study: | 6 Years to 15 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
Children with ADHD treated in the Institute for Child Development at Hillel Yaffe Medical Center
Criteria
Inclusion Criteria:
- Normal development for age
- ADHD
Exclusion Criteria:
- Low compliance
- Developmental delay
- Chronic disease
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01531127
Please refer to this study by its ClinicalTrials.gov identifier: NCT01531127
Contacts
| Contact: Muhammad Mahajnah, MD, PhD | 972-506246959 | MohamedM@hy.health.gov.il |
Locations
| Israel | |
| Hillel Yaffe Medical Center | |
| Hadera, Israel, 38100 | |
Sponsors and Collaborators
Hillel Yaffe Medical Center
More Information
| Responsible Party: | Hillel Yaffe Medical Center |
| ClinicalTrials.gov Identifier: | NCT01531127 History of Changes |
| Other Study ID Numbers: |
0014-12-HYMC |
| Study First Received: | February 8, 2012 |
| Last Updated: | February 9, 2012 |
Additional relevant MeSH terms:
|
Attention Deficit Disorder with Hyperactivity Attention Deficit and Disruptive Behavior Disorders Neurodevelopmental Disorders Mental Disorders |
ClinicalTrials.gov processed this record on June 23, 2017